KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Raw Materials: 2018-2025

Historic Raw Materials for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $20.2 million.

  • Twist Bioscience's Raw Materials rose 16.60% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 16.60%. This contributed to the annual value of $20.2 million for FY2025, which is 16.60% up from last year.
  • Per Twist Bioscience's latest filing, its Raw Materials stood at $20.2 million for FY2025, which was up 16.60% from $17.3 million recorded in FY2024.
  • Twist Bioscience's 5-year Raw Materials high stood at $28.8 million for FY2022, and its period low was $17.3 million during FY2024.
  • Over the past 3 years, Twist Bioscience's median Raw Materials value was $20.2 million (recorded in 2025), while the average stood at $21.5 million.
  • In the last 5 years, Twist Bioscience's Raw Materials soared by 103.29% in 2021 and then slumped by 35.92% in 2024.
  • Twist Bioscience's Raw Materials (Yearly) stood at $18.8 million in 2021, then skyrocketed by 53.30% to $28.8 million in 2022, then dropped by 6.12% to $27.0 million in 2023, then tumbled by 35.92% to $17.3 million in 2024, then rose by 16.60% to $20.2 million in 2025.